{"version":"1.0","type":"link","title":"AQW-051 - Newikis","description":"AQW-051 also known as VQW-765 is an orally available, highly selective partial agonist of the alpha-7 nicotinic receptor (nAChR) developed by Novartis as a central nervous system agent aimed at improving cognitive function in disorders such as schizophrenia and Alzheimer's disease, and for reducing…","provider_name":"Newikis","provider_url":"https://newikis.com","cache_age":86400,"thumbnail_url":"https://thumb.wikimedia.org/wikipedia/commons/thumb/1/1a/AQW051.svg/1280px-AQW051.svg.png","thumbnail_width":1280,"thumbnail_height":565}